These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8262968)

  • 1. Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex.
    Peña A; Reddy CD; Wu S; Hickok NJ; Reddy EP; Yumet G; Soprano DR; Soprano KJ
    J Biol Chem; 1993 Dec; 268(36):27277-85. PubMed ID: 8262968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
    Peña A; Wu S; Hickok NJ; Soprano DR; Soprano KJ
    J Cell Physiol; 1995 Feb; 162(2):234-45. PubMed ID: 7822433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs.
    Tobias KE; Shor J; Kahana C
    Oncogene; 1995 Nov; 11(9):1721-7. PubMed ID: 7478599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
    Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
    Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of the ornithine decarboxylase gene by c-Myc/Max/Mad network and retinoblastoma protein interacting with c-Myc.
    Auvinen M; Järvinen K; Hotti A; Okkeri J; Laitinen J; Jänne OA; Coffino P; Bergman M; Andersson LC; Alitalo K; Hölttä E
    Int J Biochem Cell Biol; 2003 Apr; 35(4):496-521. PubMed ID: 12565711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene.
    Walhout AJ; Gubbels JM; Bernards R; van der Vliet PC; Timmers HT
    Nucleic Acids Res; 1997 Apr; 25(8):1493-501. PubMed ID: 9162900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?
    Mol PC; Wang RH; Batey DW; Lee LA; Dang CV; Berger SL
    Mol Cell Biol; 1995 Dec; 15(12):6999-7009. PubMed ID: 8524267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ornithine decarboxylase gene is a transcriptional target of c-Myc.
    Bello-Fernandez C; Packham G; Cleveland JL
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7804-8. PubMed ID: 8356088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hnRNP U interacts with the c-Myc-Max complex on the E-box promoter region inducing the ornithine decarboxylase gene.
    Matsuoka Y; Uehara N; Tsubura A
    Oncol Rep; 2009 Aug; 22(2):249-55. PubMed ID: 19578763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequences flanking the E-box contribute to cooperative binding by c-Myc/Max heterodimers to adjacent binding sites.
    Walhout AJ; van der Vliet PC; Timmers HT
    Biochim Biophys Acta; 1998 Apr; 1397(2):189-201. PubMed ID: 9565685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsaturated fatty acids bind Myc-Max transcription factor and inhibit Myc-Max-DNA complex formation.
    Chung S; Park S; Yang CH
    Cancer Lett; 2002 Dec; 188(1-2):153-62. PubMed ID: 12406560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding.
    Park S; Chung S; Kim KM; Jung KC; Park C; Hahm ER; Yang CH
    Biochim Biophys Acta; 2004 Feb; 1670(3):217-28. PubMed ID: 14980448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position and orientation independent transactivation by c-Myc.
    Packham G; Bello-Fernandez C; Cleveland JL
    Cell Mol Biol Res; 1994; 40(7-8):699-706. PubMed ID: 7787888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation by Myc is under negative control by the transcription factor AP-2.
    Gaubatz S; Imhof A; Dosch R; Werner O; Mitchell P; Buettner R; Eilers M
    EMBO J; 1995 Apr; 14(7):1508-19. PubMed ID: 7729426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression.
    Iyengar RV; Pawlik CA; Krull EJ; Phelps DA; Burger RA; Harris LC; Potter PM; Danks MK
    Cancer Res; 2001 Apr; 61(7):3045-52. PubMed ID: 11306486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of c-myc and max in CNS beta-endorphin modulation of hepatic ornithine decarboxylase responsiveness to insulin in rat pups.
    Bartolome JV; Wang S; Schanberg SM; Bartolome MB
    Life Sci; 1999; 64(5):PL87-91. PubMed ID: 10072196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
    Packham G; Cleveland JL
    Oncogene; 1997 Sep; 15(10):1219-32. PubMed ID: 9294616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG-I/Y, a new c-Myc target gene and potential oncogene.
    Wood LJ; Mukherjee M; Dolde CE; Xu Y; Maher JF; Bunton TE; Williams JB; Resar LM
    Mol Cell Biol; 2000 Aug; 20(15):5490-502. PubMed ID: 10891489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Max: functional domains and interaction with c-Myc.
    Kato GJ; Lee WM; Chen LL; Dang CV
    Genes Dev; 1992 Jan; 6(1):81-92. PubMed ID: 1730412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of the Myc-Max mediated transactivation in yeast by natural promoter elements.
    Hänel F; Peukert K; Munder T
    J Basic Microbiol; 1997; 37(1):23-8. PubMed ID: 9090124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.